Trial of BKM120/Tamoxifen-combination in Patients With HR-pos, HER2-neg Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: BKM120|DRUG: Tamoxifen
Sponsor: University Hospital, Essen
Collaborators: iOMEDICO AG|Novartis Pharmaceuticals